Notice

Error
  • Error loading feed data
  • Error loading feed data

PRCSG News

Abstracts  / Posters / Presentations

 

German Society For Rheumatology 47th Congress, September 04 - 07, 2019

  • Poster: Maintenance of Clinical Response in Individual Children With Juvenile Idiopathic Arthritis Treated with Subcutaneous Abatacept. 

 

*******************************************************************************************

April 2019 - FDA approves Benlysta (belimumab) for children with lupus who are five years old or above

 

September 2018 - FDA approves subcutaneous formulation of ACTEMRA for systemic JIA 

 

Revised Common Rule: educational videos created by OHRP

 

May 2018 - FDA approves subcutaneous formulation of Actemra for use is Polyarticular Juvenile Idiopathic Arthritis